Treatment of COVID-19 late consequences (Q4297638)
Jump to navigation
Jump to search
Project Q4297638 in Denmark
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of COVID-19 late consequences |
Project Q4297638 in Denmark |
Statements
3,629,271.0 Euro
0 references
4,839,186.0 Euro
0 references
75.0 percent
0 references
1 May 2021
0 references
30 September 2022
0 references
Region Sjælland - Sjællands Universitetshospital
0 references
55°27'27.11"N, 12°10'55.85"E
0 references
Behandling af COVID-19 senfølger arbejder for bedre at forstå senfølgerne fra corona og finde bedre måder at kunne afbøde dem. Corona-pandemien har sat tydelige spor på vores samfund økonomisk, socialt og sundhedsmæssigt. Pandemien ser ud til at følge os mange år endnu med alvorlige senfølger ikke tidligere oplevet fra influenza- og andre virusepidemier. COVID-19 er en ny sygdom. Vi ved meget lidt om senfølger, hvem der er rammes og i hvor lang tid. I kølvandet på den udbredte smitte formodes et stort mørketal, hvoraf nogle lever med alvorlige senfølger af COVID-19. Projektets partnere ønsker at forstå opståen af senfølger og at kunne afbøde dem. Projektet vil skabe overblik over senfølger og forbedre behandlingen med en dansk-svensk biobank til at identificere biomarkører for senfølger, senfølgerklinikker til behandling af tydelige senfølger og kortlægge uspecifikke senfølger. Det skaber viden om, hvordan rehabiliteringen af senfølger indrettes mest optimalt. Samarbejdet vil føre til fælles løsninger ved at forene ekspertise fra både Danmark og Sverige med kompetencer inden for en række specialer, som understøttes af udgivelser omkring det videnskabelige samarbejde. (Danish)
0 references
Treating COVID-19 late followers works to better understand the late effects of the corona and find better ways to mitigate them. The Corona pandemic has made clear signs on our societies from the economic, social and health point of view. The pandemic seems to be following us for many years yet, with severe late consequences not previously experienced from influenza and other viral epidemics. COVID-19 is a new disease. We know very little about late sequences, who is affected and for how long. In the aftermath of the widespread infection, a large dark number is assumed, some of which live with severe late effects of COVID-19. The project partners want to understand the emergence of late consequences and to be able to mitigate them. The project will create an overview of late sequences and improve treatment with a Danish-Swedish biobank to identify biomarkers for late sequences, late sequence clinics for the treatment of clear late sequences and mapping non-specific late sequences. It creates knowledge of how the rehabilitation of late sequences is most optimally arranged. The collaboration will lead to joint solutions by combining expertise from both Denmark and Sweden with competencies within a number of specialties supported by publications about the scientific cooperation. (English)
21 June 2022
0 references